The store will not work correctly when cookies are disabled.
3-Amino-N-(2-ethyl-1H-indol-5-yl)pyrazine-2-carboxamide
ID: ALA4791393
PubChem CID: 162671783
Max Phase: Preclinical
Molecular Formula: C15H15N5O
Molecular Weight: 281.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCc1cc2cc(NC(=O)c3nccnc3N)ccc2[nH]1
Standard InChI: InChI=1S/C15H15N5O/c1-2-10-7-9-8-11(3-4-12(9)19-10)20-15(21)13-14(16)18-6-5-17-13/h3-8,19H,2H2,1H3,(H2,16,18)(H,20,21)
Standard InChI Key: DRZQKQODOZQWCP-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
41.0904 -13.2304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.8001 -12.8210 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7972 -11.9983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.0886 -11.5931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3824 -12.8215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3836 -12.0050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6074 -11.7514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1264 -12.4113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6054 -13.0726 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.5034 -11.5871 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.2127 -11.9930 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.9188 -11.5818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.2157 -12.8102 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.6265 -11.9911 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
45.3322 -11.5805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.3295 -10.7624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6153 -10.3567 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.9126 -10.7696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3092 -12.4102 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.2017 -10.3664 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.8996 -13.1173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
3 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 12 1 0
8 19 1 0
18 20 1 0
19 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 281.32 | Molecular Weight (Monoisotopic): 281.1277 | AlogP: 2.35 | #Rotatable Bonds: 3 |
Polar Surface Area: 96.69 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 0.98 | CX LogP: 2.25 | CX LogD: 2.25 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.69 | Np Likeness Score: -1.50 |
References
1. Alverez C,Bulfer SL,Chakrasali R,Chimenti MS,Deshaies RJ,Green N,Kelly M,LaPorte MG,Lewis TS,Liang M,Moore WJ,Neitz RJ,Peshkov VA,Walters MA,Zhang F,Arkin MR,Wipf P,Huryn DM. (2016) Allosteric Indole Amide Inhibitors of p97: Identification of a Novel Probe of the Ubiquitin Pathway., 7 (2.0): [PMID:26985295] [10.1021/acsmedchemlett.5b00396] |